![Stacey L. Jurchison](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stacey L.
Jurchison worked as a Communications Director & Head-Investor Relations at PharmAthene, Inc. from 2012 to 2014.
She also worked as a Senior Director-Investor Relations at Aptevo Therapeutics, Inc. and Altimmune, Inc. Additionally, she worked as an Executive Director-Corporate Affairs at Prelude Therapeutics, Inc. from 2019 to 2022.
Furthermore, she worked as an Investor Relations Contact & Head-Communications at Rexahn Pharmaceuticals, Inc.
Anciens postes connus de Stacey L. Jurchison
| Sociétés | Poste | Fin |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | - |
| ALTIMMUNE, INC. | Investor Relations Contact | - |
| REXAHN PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| APTEVO THERAPEUTICS INC. | Investor Relations Contact | - |
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology Develops bio therapeutics to address biological pathogens and chemicals | Health Technology |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
